Senate Committee Advances FDA Nominee

Law360 (December 3, 2019, 3:25 PM EST) -- A Senate panel on Tuesday pushed forward the nomination of oncologist Stephen M. Hahn to head the U.S. Food and Drug Administration, despite concerns about his commitment to tougher e-cigarette regulations.

By a bipartisan vote of 18-5, the Senate Health, Education, Labor and Pensions Committee approved Hahn's nomination for FDA commissioner. However, Sen. Patty Murray of Washington, the committee's top Democrat, said she was voting against his nomination given his refusal during a hearing last month to commit to enforcing stronger regulations on e-cigarettes.

"I was particularly concerned that when pressed, from both sides of the aisle, Dr. Hahn refused to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS